SCHEMBL13506191

SCHEMBL13506191

NC(=O)c1ccc(NC(=O)Oc2ccccc2)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.54
▸ MAPT P10636 5/20 0.54
▸ RAD51 Q06609 1/20 0.52
▸ KMT2A Q03164 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ THRB P10828 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ GAA P10253 3/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ P4HTM Q9NXG6 1/20 0.48
▸ FAAH O00519 6/20 0.47
▸ HTT P42858 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NAMPT P43490 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL896314 0.81 KCNQ3 (0.64) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL20379645 0.80 MAPT (0.54) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL14659919 0.80 ALDH1A1 (0.54) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL896599 0.79 ALDH1A1 (0.56) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL1010493 0.79 ALDH1A1 (0.56) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL29644563 0.79 ALDH1A1 (0.60) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL31728525 0.79 ALDH1A1 (0.56) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL1013306 0.79 ALDH1A1 (0.60) ALDH1A1MAPTRAD51KMT2AKDM4E
SCHEMBL24756022 0.79 ALDH1A1 (0.55) ALDH1A1MAPTRAD51KMT2AKDM4E
Hydrochloric Acid SCHEMBL31090358 0.78 ALDH1A1 (0.59) ALDH1A1MAPTRAD51KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029978-A1 NOVEL ARYL UREA DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. 2013-01-31 — — US disclosed
US-20130029978-A1 NOVEL ARYL UREA DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. 2013-01-31 — — US disclosed
US-20130029978-A1 NOVEL ARYL UREA DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. 2013-01-31 — — US disclosed
EP-2518064-A1 NOVEL ARYL UREA DERIVATIVE Mochida Pharmaceutical Co., Ltd. (JP) 2012-10-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029978-A1 NOVEL ARYL UREA DERIVATIVE FAAH, FAAH2, NAT1 ALDH1A1 210/4885MAPT 2928/4885RAD51 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback